LOS ANGELES - Kairos Pharma, Ltd. (NYSE American:KAPA) a conclu des conditions contraignantes pour acquérir CL-273, un inhibiteur EGFR expérimental pour le traitement du cancer du poumon, auprès de Ce ...
Une étude montre que certaines bactéries intestinales influencent la survie des chiens traités par immunothérapie contre le cancer.
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:50 AM ESTCompany ParticipantsAdam Lenkowsky - Executive ...
7h
Summit Therapeutics Inc. (SMMT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
TD Cowen 46th Annual Health Care Conference March 2, 2026 2:30 PM ESTCompany ParticipantsDave Gancarz - Chief Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results